SCHEMBL4347397

SCHEMBL4347397

Cc1cccc(CNc2ccc(F)c(F)c2O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
BRD9 Q9H8M2 1/20 0.41
HDAC4 P56524 1/20 0.39
MEF2D Q14814 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39
DRD1 P21728 1/20 0.38
HTR2A P28223 1/20 0.38
MMP13 P45452 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
MAOB P27338 1/20 0.38
APP P05067 1/20 0.38
MAPT P10636 2/20 0.38
GFER P55789 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345895 0.85 BRD4 (0.43) BRD4BRD9TAAR1AURKARPS6KB1
SCHEMBL4348974 0.81 RXFP1 (0.49) TAAR1AURKARPS6KB1APPCYP1A2
SCHEMBL4345422 0.79 FFAR1 (0.49) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL4351097 0.78 GFER (0.45) HDAC4MEF2DTAAR1MMP13ADORA2A
SCHEMBL4356057 0.77 ALDH1A1 (0.52) BRD4MMP13MAPTSMN1; SMN2ALDH1A1
SCHEMBL27761107 0.77 BRD4 (0.50) BRD4BRD9AURKARPS6KB1DRD1
SCHEMBL4355854 0.77 MEN1 (0.60) MAOBMAPTALDH1A1MEN1KMT2A
SCHEMBL4346359 0.77 BRD4 (0.49) BRD4BRD9AURKARPS6KB1DRD1
SCHEMBL4344413 0.76 MEN1 (0.44) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL25547424 0.75 BRD4 (0.42) BRD4BRD9TAAR1MAOBAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 BRD4 2590/4885BRD9 3597/4885HDAC4 626/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 BRD4 514/4885BRD9 2070/4885HDAC4 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.